Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | 1,800,000 | reported | 03 Feb 2026 | tx 14+3,784,672 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Feb 2026 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 1,800,000 | 0.00 USD | deriv |
| 26 Aug 2025 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 600,000 | 0.00 USD | deriv |
| 21 Feb 2024 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 140,000 | 0.00 USD | deriv |
| 14 Mar 2023 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 275,000 | 0.00 USD | deriv |
| 13 Sept 2022 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 274,875 | 0.00 USD | deriv |
| 16 Mar 2022 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 24,972 | 0.00 USD | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 104,689 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 81,425 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 69,793 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 11,632 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 108,086 | — | deriv |